0001829522-20-000001.txt : 20201023 0001829522-20-000001.hdr.sgml : 20201023 20201023162530 ACCESSION NUMBER: 0001829522-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201023 DATE AS OF CHANGE: 20201023 EFFECTIVENESS DATE: 20201023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Antlia Bioscience, Inc. CENTRAL INDEX KEY: 0001829522 IRS NUMBER: 844808002 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-378760 FILM NUMBER: 201257986 BUSINESS ADDRESS: STREET 1: 1281 HYMETTUS AVE CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: 619-990-0290 MAIL ADDRESS: STREET 1: 1281 HYMETTUS AVE CITY: ENCINITAS STATE: CA ZIP: 92024 D 1 primary_doc.xml X0708 D LIVE 0001829522 Antlia Bioscience, Inc. 1281 HYMETTUS AVE ENCINITAS CA CALIFORNIA 92024 619-990-0290 DELAWARE None None Corporation true 2020 Brian Laurence Johnson 1281 Hymettus Ave. Encinitas CA CALIFORNIA 92024 Executive Officer Director Other Technology Decline to Disclose 06b false 2020-10-14 false true true false 0 600000 207000 393000 false 7 0 0 0 The gross proceeds of the offering will be used for operating expenses, working capital and other general corporate purposes. false Antlia Bioscience, Inc. Brian Laurence Johnson Brian Laurence Johnson Chief Executive Officer 2020-10-23